Tag: NASDAQ:INSY

Finance

Active Watch List: INSYS Therapeutics (NASDAQ:INSY), Celladon Corporation (NASDAQ:CLDN), WisdomTree Investments, Inc. (NASDAQ:WETF), Arotech Corporation (NASDAQ:ARTX), DigitalGlobe, Inc. (NYSE:DGI)

Insys Therapeutics, Inc. (NASDAQ:INSY) announced that the FDA has granted orphan drug status to its pharmaceutical cannabidiol (CBD), for the treatment of glioblastoma multiforme (GBM.V). Glioblastoma multiforme is the most common and aggressive form of malignant primary brain tumor. INSYS Therapeutics, Inc. (NASDAQ:INSY) belongs to Healthcare sector. Its net profit margin is 31.70% and weekly performance is -4.03%. On last trading day company shares ended … Continue reading Active Watch List: INSYS Therapeutics (NASDAQ:INSY), Celladon Corporation (NASDAQ:CLDN), WisdomTree Investments, Inc. (NASDAQ:WETF), Arotech Corporation (NASDAQ:ARTX), DigitalGlobe, Inc. (NYSE:DGI)

Jason Knox
Finance

Investors Are Watching : Linear Technology (NASDAQ:LLTC), Technical Communications (NASDAQ:TCCO), Vaalco Energy (NYSE:EGY), INSYS Therapeutics (NASDAQ:INSY), Marrone Bio (NASDAQ:MBII)

On 17 JULY Linear Technology Corporation (NASDAQ:LLTC) said that it is again eyeing Camas for a major expansion, and a decision could come later this summer. Linear Technology Corporation (NASDAQ:LLTC) belongs to Technology sector. Its net profit margin is 33.10% and weekly performance is -2.38%. On last trading day company shares ended up $44.25. Linear Technology Corporation (NASDAQ:LLTC) distance from 50-day simple moving average (SMA50) … Continue reading Investors Are Watching : Linear Technology (NASDAQ:LLTC), Technical Communications (NASDAQ:TCCO), Vaalco Energy (NYSE:EGY), INSYS Therapeutics (NASDAQ:INSY), Marrone Bio (NASDAQ:MBII)

Jason Knox
Finance

Investors Watch List : MER Telemanagement (NASDAQ:MTSL), CSP (NASDAQ:CSPI), PMC-Sierra (NASDAQ:PMCS), INSYS Therapeutics (NASDAQ:INSY), Cypress Semiconductor (NASDAQ:CY)

MER Telemanagement Solutions Ltd. (NASDAQ:MTSL) belongs to Technology sector. Its net profit margin is 7.30% and weekly performance is -2.80%. On last trading day company shares ended up $1.39. MER Telemanagement Solutions Ltd. (NASDAQ:MTSL) distance from 50-day simple moving average (SMA50) is -8.02%. CSP Inc. (NASDAQ:CSPI) , a provider of IT solutions, systems integration services and dense cluster computing systems, announced that it will issue its … Continue reading Investors Watch List : MER Telemanagement (NASDAQ:MTSL), CSP (NASDAQ:CSPI), PMC-Sierra (NASDAQ:PMCS), INSYS Therapeutics (NASDAQ:INSY), Cypress Semiconductor (NASDAQ:CY)

Colin Pettis
Finance

Biotech Insider Buying: Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros (NASDAQ:OMER), Insys Therapeutics (NASDAQ:INSY), Agios Pharmaceuticals (NASDAQ:AGIO), BioTime (NYSEMKT:BTX)

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Director Gary L. Crocker bought 36,000 shares of the stock in a transaction dated Monday, June 23rd. The shares were purchased at an average price of $6.84 per share, with a total value of $246,240.00. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock performance was 3.91% in last session and finished the day at $7.44. Traded volume was 1.38million shares in the last session … Continue reading Biotech Insider Buying: Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros (NASDAQ:OMER), Insys Therapeutics (NASDAQ:INSY), Agios Pharmaceuticals (NASDAQ:AGIO), BioTime (NYSEMKT:BTX)

Ryan Holtz
Finance

Small Cap Insider Buying: Hercules Offshore (NASDAQ:HERO), Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros Corporation (NASDAQ:OMER), Insys (NASDAQ:INSY), New Mountain Finance (NYSE:NMFC)

Hercules Offshore Inc (NASDAQ:HERO) Director Thomas R. Bates, Jr. purchased 20,000 shares of the stock on the open market in a transaction that occurred on Tuesday, June 24th. The stock was purchased at an average price of $3.93 per share, for a total transaction of $78,600.00. Following the completion of the transaction, the director now directly owns 280,000 shares in the company, valued at approximately … Continue reading Small Cap Insider Buying: Hercules Offshore (NASDAQ:HERO), Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros Corporation (NASDAQ:OMER), Insys (NASDAQ:INSY), New Mountain Finance (NYSE:NMFC)

Kristen Barton
Finance

Biotech Insider Buying: OvaScience Inc (NASDAQ:OVAS), BioTime (NYSEMKT:BTX), Insys Therapeutics (NASDAQ:INSY), Novavax (NASDAQ:NVAX), ImmuCell Corporation (NASDAQ:ICCC)

Ovascience Inc (NASDAQ:OVAS) major shareholder Fund L.P. Longwood bought 100,000 shares of the company’s stock on the open market in a transaction dated Friday, March 7th. The stock was purchased at an average cost of $10.00 per share, for a total transaction of $1,000,000.00. OvaScience Inc (NASDAQ:OVAS) stock performance was -2.98% in last session and finished the day at $8.47. Traded volume was 69,618.00million shares … Continue reading Biotech Insider Buying: OvaScience Inc (NASDAQ:OVAS), BioTime (NYSEMKT:BTX), Insys Therapeutics (NASDAQ:INSY), Novavax (NASDAQ:NVAX), ImmuCell Corporation (NASDAQ:ICCC)

Jason Knox